Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

286.79 +7.32 (+2.62%)

Delayed Quote Updated: 12:26 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)

July 06, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence Economy

1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky

July 06, 2026

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Via StockStory

Topics Energy

Prediction: Grail Stock Will Skyrocket to $100 in 1 Year ↗

July 02, 2026

The cancer test maker still has a bright future.

Via The Motley Fool

3 Mid-Cap Stocks That Concern Us

July 02, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

Illumina Q1 2026 Earnings Beat Overshadowed by Revenue Miss, ILMN Slides ↗

April 30, 2026

Via Chartmill

Topics Earnings

Why Illumina (ILMN) Stock Is Down Today

June 30, 2026

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge...

Via StockStory

Why Illumina (ILMN) Stock Is Trading Up Today

June 24, 2026

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to ...

Via StockStory

June 16, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

Topics Artificial Intelligence

Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗

June 08, 2026

Grail is on a quest to win in a $50 billion market.

Via The Motley Fool

CalTek Staffing Earns Spot on Two Forbes 2026 Best Of Lists

June 04, 2026

Via AB Newswire

Is Grail Stock a Bad-News Buy After Its Recent Pullback? ↗

June 04, 2026

The cancer test maker could still have a bright future.

Via The Motley Fool

1 Cash-Producing Stock Worth Investigating and 2 We Question

June 01, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

3 Healthcare Stocks That Fall Short

May 28, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking...

Via StockStory

This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street ↗

May 18, 2026

Grail's Galleri trial was disappointing, but it isn't down for the count yet.

Via The Motley Fool

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

May 18, 2026

Illumina has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15% to $140.33 pe...

Via StockStory

Topics Stocks

1 Surging Stock on Our Buy List and 2 Facing Challenges

May 14, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

PacBio (PACB) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

PacBio (PACB) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call

May 07, 2026

Illumina’s first quarter reflected consistent execution across its clinical and instrument businesses. Management highlighted strong demand in clinical seque...

Via StockStory

Topics Earnings

3 Profitable Stocks We’re Skeptical Of

May 06, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

May 05, 2026

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after the bell. Here’s what to look for. 10x Genomics beat analys...

Via StockStory

PacBio (PACB) Q1 Earnings Report Preview: What To Look For

May 05, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting earnings this Thursday after market hours. Here’s what investors should kn...

Via StockStory

Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades' ↗

May 05, 2026

CNBC's Halftime Report Final Trades featured Bryn Talkington's final trade of Uber, whose shares fell 1.6% to close at $73.93 on Monday.

Via Benzinga

ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges

May 01, 2026

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 4.8% year on year to $1.09 bill...

Via StockStory

Illumina (ILMN) Q1 2026 Earnings Transcript ↗

April 30, 2026

Illumina (ILMN) Q1 2026 Earnings Transcript

Via The Motley Fool

Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026

April 30, 2026

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 4.8% year on year to $1.09 billi...

Via StockStory

Illumina (ILMN) Q1 Earnings Report Preview: What To Look For

April 28, 2026

Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what to look for. Illumina beat analysts’ revenue expectat...

Via StockStory

Topics Artificial Intelligence

UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades' ↗

April 20, 2026

Stephen Weiss recommends Netflix as final trade, while Jason Snipe likes BlackRock. Amy Raskin suggests Illumina and Jenny Harrington chooses UPS.

Via Benzinga

Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A

April 15, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...

Via MarketMinute

Topics Economy

3 Unpopular Stocks That Concern Us

April 13, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

Via StockStory

3 Reasons to Avoid ILMN and 1 Stock to Buy Instead

April 09, 2026

In a sliding market, Illumina has defied the odds, trading up to $126.99 per share. Its 31.7% gain since October 2025 has outpaced the S&P 500’s 1.8% drop. T...

Via StockStory

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Penticton Herald

Penticton Herald

Illumina, Inc. - Common Stock (NQ:ILMN)

All News about Illumina, Inc. - Common Stock

Contact us

Sections

Services

Search